Viewing Study NCT01938833


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-01-31 @ 9:01 PM
Study NCT ID: NCT01938833
Status: TERMINATED
Last Update Posted: 2025-05-16
First Post: 2013-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-negative Breast Cancer View
None Inflammatory Breast Cancer View
None Male Breast Cancer View
None Recurrent Breast Cancer View
None Stage IV Breast Cancer View
Keywords: